Centre to cap profit on drugs

DECCAN CHRONICLE | ANIMESH SINGH
Published Dec 25, 2015, 8:46 am IST
Updated Mar 26, 2019, 2:56 pm IST
Panel headed by a joint secretary of the pharmaceuticals department tabled its report.
Generic Drugs (Representational image)
 Generic Drugs (Representational image)

New Delhi: After concern expressed by the Prime Minister’s Office (PMO) on exorbitant prices of generic drugs — unbranded medicines which are sold by manufacturers through distributors without any marketing or promotion - a pharmaceuticals department panel is learnt to have suggested a significant capping on profit margin of such drugs, which could even be up to 50 per cent.

According to sources, the panel, headed by a joint secretary of the pharmaceuticals department, tabled its report and is said to have suggested capping of profit margins of manufacturers of such drugs.

 

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
-->